CX-717

DB05047IllicitInvestigationalSmall molecule

CX-717 is an ampakine compound previously investigated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and Alzheimer's disease.

Chemical structure of CX-717
Mechanism
Curator reviewed
Primary indication
Investigated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and Alzheimer's disease.Curator reviewed
Formula / weight
C11H11N3O3 · 233.227 g/mol (avg)
Code names
CX-717

Resolves to

Structure
InChIKeyKFRQROSRKSVROW-UHFFFAOYSA-NSMILESO=C(N1CCOCC1)C1=CC2=NON=C2C=C1

What you can answer from here — as of December 23, 2020

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with CX-717, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account